mitoxantrone has been researched along with alpha-Chain Disease in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barista, I | 1 |
| Tekuzman, G | 1 |
| Firat, D | 1 |
| Baltali, E | 1 |
| Kansu, E | 1 |
| Kars, A | 1 |
| Ozisik, Y | 1 |
| Ruacan, S | 1 |
| Uzunalimoğlu, B | 1 |
| Karaağaoğlu, E | 1 |
1 other study available for mitoxantrone and alpha-Chain Disease
| Article | Year |
|---|---|
Non-Hodgkin's lymphomas in Turkey: eighteen years' experience at the Hacettepe University.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anemia; Antineoplastic Agents; Ant | 1994 |